سیویلیکا را در شبکه های اجتماعی دنبال نمایید.

Hypolipidemic and Hepatoprotective Effects of Myricitrin and Solid Lipid Nanoparticle-containing Myricitrin on the Male Mouse Model with Type 2 Diabetes Induced by Streptozotocin-Nicotinamide

Publish Year: 1400
Type: Journal paper
Language: English
View: 163

This Paper With 11 Page And PDF Format Ready To Download

Export:

Link to this Paper:

Document National Code:

JR_JKMU-28-1_004

Index date: 9 January 2023

Hypolipidemic and Hepatoprotective Effects of Myricitrin and Solid Lipid Nanoparticle-containing Myricitrin on the Male Mouse Model with Type 2 Diabetes Induced by Streptozotocin-Nicotinamide abstract

Background: Type 2 diabetes mellitus (T2DM) has several complications such as hyperlipidemia and hepatotoxicity. Myricitrin has an antidiabetic action along with low bioavailability. So, the aim of the present study was to investigate hypolipidemic and hepatoprotective effects of myricitrin and solid lipid nanoparticle (SLN) containing myricitrin on the T2DM mouse model induced by Streptozotocin-nicotinamide (STZ-NA). Methods: In this experimental study, 90 Naval Medical Research Institute (NMRI) adult male mice were divided into 9 groups (n=10 per group): control, vehicle, diabetic, diabetic + myricitrin, or SLN containing myricitrin 1, 3, and 10 mg/kg groups. The cold homogenization method was used to prepare SLN containing myricitrin. The diabetic model was induced by one injection of STZ-NA (65-120 mg/kg) with a 15-min interval. Animals' treatment was done for 4 weeks. At the end of the experiment, plasma samples were taken for experimental assessments. Results: Plasma level of triglyceride (TG), low-density lipoprotein (LDL-C), very-low-density lipoprotein (VLDL), aspartate aminotransferase (AST), and alanine aminotransferase (ALT) increased and high-density lipoprotein cholesterol (HDL-C) decreased in diabetic mice compared to the control group (p <0.05). Administration of myricitrin or SLN containing myricitrin decreased plasma levels of TG, LDL-C, VLDL, AST, and ALT and increased HDL-C in the treated diabetic groups compared to the untreated groups (p <0.05). Conclusion: According to the results, myricitrin and SLN containing myricitrin showed hypolipidemic and hepatoprotective effects in T2DM mice. Also, SLN containing myricitrin was more potent than myricitrin especially in a low dose of administration.

Hypolipidemic and Hepatoprotective Effects of Myricitrin and Solid Lipid Nanoparticle-containing Myricitrin on the Male Mouse Model with Type 2 Diabetes Induced by Streptozotocin-Nicotinamide Keywords:

Hypolipidemic and Hepatoprotective Effects of Myricitrin and Solid Lipid Nanoparticle-containing Myricitrin on the Male Mouse Model with Type 2 Diabetes Induced by Streptozotocin-Nicotinamide authors

Akram Ahangarpour

Professor of Physiology, Department of Physiology, Faculty of Medicine, Diabetes Research Center, Health Research Institute, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran

Ali Akbar Oroojan

Assistant Professor of Physiology, Department of Physiology, Faculty of Medicine, Cellular and Molecular Research Center, Student Research Committee, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran

Layasadat Khorsandi

Associate Professor of Medical Histology, Department of Anatomical Sciences, Faculty of Medicine, Cellular and Molecular Research Center, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran

Maryam Kouchak

Professor of Pharmaceutics, Department of Pharmaceutics, Faculty of Pharmacy, Nanotechnology Research Center, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran

Mohammad Badavi

Professor of Physiology, Department of Physiology, Faculty of Medicine, Physiology Research Center, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran

مراجع و منابع این Paper:

لیست زیر مراجع و منابع استفاده شده در این Paper را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود Paper لینک شده اند :
Mahboobi S, Rahimi F, Jafarnejad S. Effects of prebiotic and ...
Blaslov K, Naranđa FS, Kruljac I, Renar IP. Treatment approach ...
Vergès B. Pathophysiology of diabetic dyslipidaemia: where are we? Diabetologia ...
Fernández-Gaxiola AC, Valdés-Ramos R, Fulda KG, López AL, Martínez-Carrillo BE, ...
Akhlaghi M, Foshati S. Bioavailability and metabolism of flavonoids: a ...
Yan LJ, Yang HT, Duan HY, Wu JT, Qian P, ...
Zhang B, Shen Q, Chen Y, Pan R, Kuang S, ...
White PA, Cercato LM, Batista VS, Camargo EA, De Lucca ...
Ramteke KH, Joshi SA, Dhole SN. Solid lipid nanoparticle: a ...
Szkudelski T. Streptozotocin–nicotinamide-induced diabetes in the rat. Characteristics of the ...
Ghasemi A, Khalifi S, Jedi S. Streptozotocin-nicotinamide-induced rat model of ...
Ahangarpour A, Oroojan AA, Khorsandi L, Kouchak M, Badavi M. ...
Ahangarpour A, Oroojan AA, Khorsandi L, Arzani G, Afshari G. ...
Meotti FC, Posser T, Missau FC, Pizzolatti MG, Leal RB, ...
Schwanke RC, Marcon R, Meotti FC, Bento AF, Dutra RC, ...
Ahangarpour A, Alboghobeish S, Rezaei M, Khodayar MJ, Oroojan AA, ...
Daniel MJ. Lipid management in patients with type ۲ diabetes. ...
Sugden M, Holness M. Pathophysiology of diabetic dyslipidemia: implications for ...
Testa R, Bonfigli AR, Genovese S, De Nigris V, Ceriello ...
Kawser Hossain M, Abdal Dayem A, Han J, Yin Y, ...
Gao J, Chen S, Qiu Z, Fang L, Zhang L, ...
Ahn HR, Shin MH, Nam HS, Park KS, Lee YH, ...
Kanter M. Protective effect of quercetin on liver damage induced ...
Johari H, Nozari M, Moghtari M, Zamani Z, Yazdani M. ...
Domitrović R, Rashed K, Cvijanović O, Vladimir-Knežević S, Škoda M, ...
Ruiz-Cruz S, Chaparro-Hernández S, Hernández-Ruiz KL, Cira-Chávez LA, Estrada-Alvarado MI, ...
Eghbaliferiz S, Iranshahi M. Prooxidant activity of polyphenols, flavonoids, anthocyanins ...
نمایش کامل مراجع